The Virginia-class fast-attack submarine USS Vermont (SSN 792) is operating in the US 4th Fleet area of operations and conducted a brief stop for logistics in Rio de Janeiro December 10-15.
In Brazil, a mass inoculation campaign against Covid 19 will only be possible from March and will rely on the Astra Zeneca vaccine, a senior health official at the country’s leading public biomedical institute told Reuters.
Brazil once again risks losing its vote at the United Nations if it doesn’t pay a portion of what it owes to the global organization, which is facing a growing cash crunch as the Covid-19 crisis puts pressure on budgets worldwide.
New York City intensive care unit nurse on Monday became the first person in the United States to receive a coronavirus vaccine, calling it a sign that “healing is coming,” as the nation’s COVID-19 death toll crossed a staggering 300,000 lives lost.
Argentina's current government has had a wild ride in its first year of government: a sovereign default, huge debt restructurings together with sliding reserves, a currency crisis, a weak economy battered by COVID-19, and massive money printing.
Rail companies from China have signed agreements worth US$ 4.7bn with the government of Argentina, aimed at improving the country’s rail system.
A research mission to determine the impact of the giant A-68a iceberg on one of the world’s most important ecosystems gets underway next month. A team of scientists, led by British Antarctic Survey (BAS), will set sail on the National Oceanography Centre’s (NOC) ship bound for the sub-Antarctic island of South Georgia.
Mercosur countries will address environmental concerns raised by the European Union that have stalled ratification of a free trade deal between the two trade blocs, Argentina’s foreign minister said on Monday.
Distrust in Europe of Brazilian President Jair Bolsonaro's government is holding up ratification of a trade deal between the European Union and Mercosur, the EU ambassador to Brasilia said.
Brazil's Sao Paulo state delayed on Monday the release of efficacy data for the COVID-19 vaccine developed by China's Sinovac, tightening the timeframe for the regulator approval before a planned roll out on Jan. 25.